The store will not work correctly when cookies are disabled.
(1S,4S)-2-methyl-5-(5-phenylpyrazin-2-yl)-2,5-diazabicyclo[2.2.1]heptane
ID: ALA1083617
PubChem CID: 46891589
Max Phase: Preclinical
Molecular Formula: C16H18N4
Molecular Weight: 266.35
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CN1C[C@@H]2C[C@H]1CN2c1cnc(-c2ccccc2)cn1
Standard InChI: InChI=1S/C16H18N4/c1-19-10-14-7-13(19)11-20(14)16-9-17-15(8-18-16)12-5-3-2-4-6-12/h2-6,8-9,13-14H,7,10-11H2,1H3/t13-,14-/m0/s1
Standard InChI Key: RKHDYSPQWSSHAH-KBPBESRZSA-N
Molfile:
RDKit 2D
22 25 0 0 0 0 0 0 0 0999 V2000
-4.4828 1.4220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6675 1.4220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2614 2.1259 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.6675 2.8368 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.4828 2.8368 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.8959 2.1259 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.4487 2.1259 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0414 1.4167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2274 1.4145 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.8149 2.1244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2257 2.8346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0418 2.8315 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.7112 2.1242 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.4892 1.9888 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.4892 3.6574 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
-3.6740 0.6068 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
0.0112 2.1229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4237 1.4040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2508 1.4028 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6662 2.1198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2486 2.8395 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4229 2.8371 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5 6 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
3 7 1 0
6 13 1 0
5 14 1 0
2 14 1 0
5 15 1 1
2 16 1 1
1 2 1 0
17 18 2 0
1 6 1 0
18 19 1 0
2 3 1 0
19 20 2 0
3 4 1 0
20 21 1 0
4 5 1 0
21 22 2 0
22 17 1 0
10 17 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 266.35 | Molecular Weight (Monoisotopic): 266.1531 | AlogP: 2.04 | #Rotatable Bonds: 2 |
Polar Surface Area: 32.26 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 7.61 | CX LogP: 2.13 | CX LogD: 1.71 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.83 | Np Likeness Score: -0.58 |
References
1. Li T, Bunnelle WH, Ryther KB, Anderson DJ, Malysz J, Helfrich R, Grønlien JH, Håkerud M, Peters D, Schrimpf MR, Gopalakrishnan M, Ji J.. (2010) Syntheses and structure-activity relationship (SAR) studies of 2,5-diazabicyclo[2.2.1]heptanes as novel alpha7 neuronal nicotinic receptor (NNR) ligands., 20 (12): [PMID:20472430] [10.1016/j.bmcl.2010.04.105] |